About cITP
OCTAGAM 10% results
OCTAGAM 10% is an FDA-approved treatment that was studied in a clinical trial for adults with cITP, where it was shown to boost platelet counts.
Explore these helpful topics to see if OCTAGAM 10% can help you on your treatment journey with cITP.
Chronic immune thrombocytopenia (cITP) is a rare autoimmune disorder that can lead to excessive bruising or bleeding.
Patients with cITP have low levels of certain blood cells called platelets, which are essential to helping the blood to clot. This condition is caused by your own immune system attacking the platelets in your blood, which is why it is called an autoimmune disorder. ITP is considered chronic when it lasts for more than 12 months.
Symptoms of cITP vary greatly between individuals and the severity of your condition. Signs of bleeding may include:
- Petechiae (pe-TEEK-ee-ay), which are small, flat, red dots on the skin caused by blood leaking from blood vessels
- Purpura, which is bleeding under your skin that can cause red, purple, or brownish-yellow spots
- Nosebleeds or bleeding from your gums
- Blood in urine or stools
- Heavy menstrual bleeding
- Extreme tiredness
- Pale skin color, dizziness, and tiredness if bleeding causes anemia
Depending on the severity of your cITP, you may require care from a multidisciplinary team of healthcare providers. In addition to your primary care physician, your team may include hematologists, pharmacologists, and nurses, among others. It’s important to talk about your symptoms with your healthcare professionals. They will all work together with you on your cITP treatment plan.
Getting started with
OCTAGAM 10%
View helpful info on what to
expect before, during, and after
OCTAGAM 10% infusions
Have questions about
OCTAGAM 10%?
Find answers to frequently asked questions and get connected to additional support
Find savings and resources
View co-pay program info, where
eligible patients may pay as little
as $0,* and explore other helpful
materials and tools
*The OCTAGAM Co-Pay Program provides eligible patients assistance of up to $12,500 per year. Once a patient reaches the annual maximum benefit, patient is responsible for paying the remaining monthly out-of-pocket costs. The OCTAGAM Co-Pay Program is good only in the US and Puerto Rico. No membership fees. Federal and state health care beneficiaries are not eligible. Private insurance only. Eligibility and restrictions apply. See full Terms and Conditions on the Support and financial assistance page.
Want to connect with other patients diagnosed with cITP?
The Platelet Disorder Support Association offers education and support to individuals and families affected by cITP
The link above is for your convenience. This website is neither owned nor controlled by Pfizer. Pfizer does not endorse and is not responsible for the content or services of this site.
In the trial, 116 adult patients with newly diagnosed or chronic ITP received OCTAGAM 10% to see how well patients responded to treatment with OCTAGAM 10% by measuring the rise in platelet counts within seven days after the first infusion. The 66 patients with chronic ITP were included in the efficacy results.
The most common side effects of OCTAGAM 10% in the clinical trial were:
• Headache: 25%
• Fever: 15%
• Increased heart rate: 11%
Getting started with
OCTAGAM 10%
View helpful info on what to
expect before, during, and after
OCTAGAM 10% infusions
Have questions about
OCTAGAM 10%?
Find answers to frequently asked questions and get connected to additional support
Find savings and resources
View co-pay program info, where
eligible patients may pay as little
as $0,* and explore other helpful
materials and tools
*The OCTAGAM Co-Pay Program provides eligible patients assistance of up to $12,500 per year. Once a patient reaches the annual maximum benefit, patient is responsible for paying the remaining monthly out-of-pocket costs. The OCTAGAM Co-Pay Program is good only in the US and Puerto Rico. No membership fees. Federal and state health care beneficiaries are not eligible. Private insurance only. Eligibility and restrictions apply. See full Terms and Conditions on the Support and financial assistance page.